Microdeletion in the <i>SHOX</i> 3′ region associated with skeletal phenotypes of Langer mesomelic dysplasia in a 45,X/46,X,r(X) infant and Leri–Weill dyschondrosteosis in her 46,XX mother: Implication for the <i>SHOX</i> enhancer
Maki Fukami(National Center For Child Health and Development), Tsutomu Ogata(Hamamatsu University School of Medicine), Gen Nishimura(Musashino University), Shunji Yamamori(Mitsubishi Group (Japan)), Torayuki Okuyama
Cited by 33
Related Papers
Rationale and study design of the Japan environment and children’s study (JECS)
|BMC Public Health|2014|852
Nosology and classification of genetic skeletal disorders: 2010 revision
|American Journal of Medical Genetics Part A|2011|717
Nosology and classification of genetic skeletal disorders: 2019 revision
|American Journal of Medical Genetics Part A|2019|620
Nosology and classification of genetic skeletal disorders: 2015 revision
|American Journal of Medical Genetics Part A|2015|570
Nosology of genetic skeletal disorders: 2023 revision
|American Journal of Medical Genetics Part A|2023|386